Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review
出版年份 2021 全文链接
标题
Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review
作者
关键词
-
出版物
Obesity Reviews
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-08-23
DOI
10.1111/obr.13326
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug Therapy in Obesity: A Review of Current and Emerging Treatments
- (2020) David M. Williams et al. Diabetes Therapy
- Safety and Effectiveness of Longer‐Term Phentermine Use: Clinical Outcomes from an Electronic Health Record Cohort
- (2019) Kristina H. Lewis et al. Obesity
- Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non‐surgical and bariatric surgery patients
- (2019) Mohamed Suliman et al. DIABETES OBESITY & METABOLISM
- Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
- (2019) Sean Wharton et al. Obesity
- THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE
- (2019) Kelly Shibuya et al. Endocrine Practice
- Management of overweight and obesity in primary care—A systematic overview of international evidence‐based guidelines
- (2019) Thomas Semlitsch et al. Obesity Reviews
- Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015
- (2019) David R. Saxon et al. Obesity
- Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery
- (2018) Peter Rye et al. OBESITY SURGERY
- Efficacy of adjuvant weight loss medication after bariatric surgery
- (2018) Zubaidah Nor Hanipah et al. Surgery for Obesity and Related Diseases
- Persistence of newer anti-obesity medications in a real-world setting
- (2018) Rahul Ganguly et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Cardiovascular Safety During and After Use of Phentermine and Topiramate
- (2018) Mary E Ritchey et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
- (2018) Lawrence Blonde et al. ADVANCES IN THERAPY
- State Variation in Obesity, Bariatric Surgery, and Economic Ranks: A Tale of Two Americas
- (2018) Eric DeMaria et al. Surgery for Obesity and Related Diseases
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Observational Comparative Effectiveness of Pharmaceutical Treatments for Obesity within the Veterans Health Administration
- (2017) Ted R. Grabarczyk PHARMACOTHERAPY
- Economic Burden of Obesity: A Systematic Literature Review
- (2017) Maximilian Tremmel et al. International Journal of Environmental Research and Public Health
- Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance
- (2016) L Aagaard et al. INTERNATIONAL JOURNAL OF OBESITY
- The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
- (2015) Ian J. Douglas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom
- (2015) J F Hayes et al. INTERNATIONAL JOURNAL OF OBESITY
- Pharmacotherapy in Conjunction with a Diet and Exercise Program for the Treatment of Weight Recidivism or Weight Loss Plateau Post-bariatric Surgery: a Retrospective Review
- (2015) Jennifer Schwartz et al. OBESITY SURGERY
- Combination phentermine and topiramate for weight maintenance: the first Australian experience
- (2014) Sandra L Neoh et al. MEDICAL JOURNAL OF AUSTRALIA
- Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status
- (2014) John Cawley et al. PHARMACOECONOMICS
- The effect of orlistat on weight reduction in obese and overweight Korean patients
- (2013) Soo Mi Ahn et al. ARCHIVES OF PHARMACAL RESEARCH
- Safety Assessment of an Anti-Obesity Drug (Sibutramine)
- (2013) Jerzy E. Tyczynski et al. DRUG SAFETY
- Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink
- (2013) I. J. Douglas et al. BMJ-British Medical Journal
- Risk of colorectal cancer after initiation of orlistat: matched cohort study
- (2013) J.-L. Hong et al. BMJ-British Medical Journal
- Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals
- (2011) Beatriz Hemo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long-Term Phentermine Pharmacotherapy for Obesity
- (2011) Ed J. Hendricks et al. Obesity
- Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study
- (2011) Sébastien Czernichow et al. European Journal of Preventive Cardiology
- Fatal and Non-Fatal Cardiovascular Events in a General Population Prescribed Sibutramine in New Zealand
- (2010) Mira Harrison-Woolrych et al. DRUG SAFETY
- Long-Term Pharmacotherapy for Obesity in Elderly Patients
- (2010) Nídia Celeste Horie et al. DRUGS & AGING
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now